William Blair analyst Brandon Vazquez has maintained their bullish stance on ALGN stock, giving a Buy rating today.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Brandon Vazquez has given his Buy rating due to a combination of factors, including Align Tech’s strong international growth and successful new product launches. The company’s sales and earnings per share exceeded expectations, driven by increased volumes among teenagers and growth in international markets, particularly with dental service organizations.
Despite some challenges in the North American market, the introduction of innovative products like ClinCheck Live, which provides quick patient plans, has bolstered confidence in the company’s future performance. Additionally, with shares trading at a favorable multiple of future earnings estimates, Vazquez maintains an optimistic outlook on Align Tech’s ability to stabilize and grow in key market segments.
In another report released today, TR | OpenAI – 4o also upgraded the stock to a Buy with a $148.00 price target.